Patents by Inventor Shridhar G. Hegde

Shridhar G. Hegde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11566010
    Abstract: Provided is a single step process for producing 2-methyltetrahydrofuran from furfuryl alcohol with high conversion rate and high selectivity towards 2-methyltetrahydrofuran.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: January 31, 2023
    Assignee: Penn A. Kem, LLC
    Inventors: Arrey B. Enyong, Shridhar G. Hegde
  • Publication number: 20220340536
    Abstract: Provided is a single step process for producing 2-methyltetrahydrofuran from furfuryl alcohol with high conversion rate and high selectivity towards 2-methyltetrahydrofuran.
    Type: Application
    Filed: April 22, 2021
    Publication date: October 27, 2022
    Inventors: Arrey B. ENYONG, Shridhar G. HEGDE
  • Patent number: 8653306
    Abstract: An improved method for the production of 2-amino-1,3-propanediol (serinol) and its bis-adduct, 2,2?-iminobis-1,3-propanediol, from dihydroxyacetone and ammonia in the presence of a hydrogenation catalyst such as Raney nickel, followed by separation using an acidic ion-exchange resin.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: February 18, 2014
    Assignee: Penn A Kem LLC
    Inventors: Shridhar G. Hegde, Lei Zhao
  • Patent number: 6909001
    Abstract: A method of making aminocyanopyridine compounds which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 is described.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: June 21, 2005
    Assignee: Pharmacia Corporation
    Inventors: David R. Anderson, Shridhar G. Hegde, Stephen A. Kolodziej, William F. Vernier, Emily J. Reinhard
  • Publication number: 20040220231
    Abstract: A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 4, 2004
    Inventors: Len F. Lee, Kevin C. Glenn, Daniel T. Connolly, David G. Corley, Daniel L. Flynn, Ashton T. Hamme, Shridhar G. Hegde, Michele A. Melton, Roger J. Schilling, James A. Sikorski, Nancy N. Wall, Jeffery A. Zablocki
  • Publication number: 20040209897
    Abstract: Compounds are described which inhibit mitogen activated protein kinase-activated protein kinase-2 (MK-2). Methods of using such compounds for the inhibition of MK-2, and for the prevention or treatment of a disease or disorder that is mediated by TNF&agr;, are described, where the method involves administering to the subject an MK-2 inhibiting compound of the present invention. Therapeutic compositions, pharmaceutical compositions and kits which contain the present MK-2 inhibiting compounds are also described.
    Type: Application
    Filed: December 19, 2003
    Publication date: October 21, 2004
    Applicant: Pharmacia Corporation
    Inventors: William F. Vernier, David R. Anderson, Dennis P. Phillion, Marvin J. Meyers, Shridhar G. Hegde, David B. Reitz, Ingrid P. Buchler, Matthew W. Mahoney, Thomas E. Rogers, Gennadiy Poda, Megh Singh, Kun K. Wu, Jin Xie
  • Patent number: 6794396
    Abstract: A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: September 21, 2004
    Assignee: Pharmacia Corporation
    Inventors: Len F. Lee, Kevin C. Glenn, Daniel T. Connolly, David G. Corley, Daniel L. Flynn, Ashton T. Hamme, Shridhar G. Hegde, Michele A. Melton, Roger J. Schilling, James A. Sikorski, Nancy N. Wall, Jeffery A. Zablocki
  • Publication number: 20040152739
    Abstract: Compounds are described which inhibit mitogen activated protein kinase-activated protein kinase-2 (MK-2). Methods of making such compounds are described, as well as a method of using them for the inhibition of MK-2, and for the prevention or treatment of a disease or disorder that is mediated by TNF&agr;, where the method involves administering to the subject an MK-2 inhibiting compound of the present invention. Pharmaceutical compositions and kits which contain the present MK-2 inhibiting compounds are also described.
    Type: Application
    Filed: December 19, 2003
    Publication date: August 5, 2004
    Applicant: Pharmacia Corporation
    Inventors: Cathleen E. Hanau, Serena Marie Mershon, Matthew J. Graneto, Marvin J. Meyers, Shridhar G. Hegde, Ingrid P. Buchler, Kun K. Wu, Shuang Liu, Kassoum Nacro
  • Publication number: 20040127714
    Abstract: A method of making aminocyanopyridine compounds which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 is described.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 1, 2004
    Applicant: Pharmacia Corporation
    Inventors: David R. Anderson, Shridhar G. Hegde, Stephen A. Kolodziej, William F. Vernier, Emily J. Reinhard
  • Publication number: 20040127519
    Abstract: A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 1, 2004
    Applicant: Pharmacia Corporation
    Inventors: Emily J. Reinhard, Stephen A. Kolodziej, David R. Anderson, Nathan W. Stehle, William F. Vernier, Len F. Lee, Shridhar G. Hegde
  • Publication number: 20040127511
    Abstract: Aminocyanopyridine compounds are described which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits are also described, which include an anminocyanopyridine MK-2 inhibiting compound.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 1, 2004
    Applicant: Pharmacia Corporation
    Inventors: David R. Anderson, William F. Vernier, Len F. Lee, Emily J. Reinhard, Shridhar G. Hegde
  • Publication number: 20040038939
    Abstract: 1 A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.
    Type: Application
    Filed: March 31, 2003
    Publication date: February 26, 2004
    Inventors: Len F. Lee, Kevin C. Glenn, Daniel T. Connolly, David G. Corley, Daniel L. Flynn, Ashton T. Hamme, Shridhar G. Hegde, Michele A. Melton, Roger J. Schilling, James A. Sikorski, Nancy N. Wall, Jeffery A. Zablocki
  • Patent number: 6605624
    Abstract: A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: August 12, 2003
    Assignee: Pharmacia Corporation
    Inventors: Len F. Lee, Kevin C. Glenn, Daniel T. Connolly, David G. Corley, Daniel L. Flynn, Ashton T. Hamme, Shridhar G. Hegde, Michele A. Melton, Roger J. Schilling, James A. Sikorski, Nancy N. Wall, Jeffery A. Zablocki
  • Patent number: 6461997
    Abstract: New herbicidal compounds are provided having the formula wherein Y is oxygen or sulfur; R1 and R2 are each independently a C1-4 hydrocarbyl group, unsubstituted or substituted with one or more halogen, haloalkyl, hydroxy, alkoxy, carboxy, amido, cyano or amino groups; or R1 and R2, together with the carbamoyl nitrogen atom to which they are attached, form a nitrogen-containing five or six membered ring, the ring being optionally interrupted by an ethereal oxygen atom and unsubstituted or substituted with one or more hydroxy, amido, cyano, amino or C1-8 alkyl, alkenyl, alkynyl, cycloalkyl, arylalkyl, alkoxy, aminoalkyl or haloalkyl groups; and R3 is hydrogen, halogen, or an alkyl, cycloalkyl, alkenyl, cycloalkenyl, cycloalkylalkenyl, aryl, arylalkyl, alkylthio or arylalkylthio group that is unsubstituted or substituted with one or more halo, hydroxy, alkoxy, acetyloxy, benzoyloxy, alkoxycarbonyl, silyl or alkylsilyl groups; or an agronomically acceptable acid addition salt or metal complex of
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: October 8, 2002
    Assignee: Monsanto Technology LLC
    Inventors: Shridhar G. Hegde, Martin D. Mahoney
  • Publication number: 20020052295
    Abstract: Novel herbicidal compounds are provided having the formula (I) 1
    Type: Application
    Filed: December 5, 2000
    Publication date: May 2, 2002
    Inventors: Shridhar G. Hegde, Daniel M. Krupa, Joseph A. Bohn, David L. Coffen, Gary R. Gustafson, Alan P. Kaplan, Yuting Ma
  • Patent number: 5129943
    Abstract: Disclosed herein are 2- or 6-fluoromethyl-3-pyridinecarboxylate derivatives with 5-[(heterocyclic)ylidene]amino substitution useful as herbicides and herbicide intermediates.
    Type: Grant
    Filed: May 20, 1991
    Date of Patent: July 14, 1992
    Assignee: Monsanto Company
    Inventors: Shridhar G. Hegde, Len F. Lee, Robert D. Bryant
  • Patent number: 5114465
    Abstract: 2- or 6-fluoromethyl-3-pyridinecarboxylate derivatives with 5-(haloalkyl) carboxamide or 5-(haloalkyl)carbamate substitution, useful as herbicides and herbicide intermediates.
    Type: Grant
    Filed: June 17, 1991
    Date of Patent: May 19, 1992
    Assignee: Monsanto Company
    Inventors: Robert D. Bryant, Shridhar G. Hegde, Len F. Lee
  • Patent number: 5112980
    Abstract: Disclosed herein is a process for cyclizing pyridinecarboxylate derivatives with 5-(haloalkyl) carboxamide or 5(haloalkyl)carbamate substitutions to prepare compounds useful as herbicides.
    Type: Grant
    Filed: May 20, 1991
    Date of Patent: May 12, 1992
    Assignee: Monsanto Company
    Inventor: Shridhar G. Hegde
  • Patent number: 5037469
    Abstract: Disclosed herein are 2- or 6-fluoromethyl-3-pyridinecarboxylate derivatives with 3- or 5-dialkylamino substitution which are useful as herbicides.
    Type: Grant
    Filed: December 27, 1989
    Date of Patent: August 6, 1991
    Assignee: Monsanto Company
    Inventors: Shridhar G. Hegde, Len F. Lee